Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch: AXTI, CENX, LABU, MX

Published 07/21/2017, 12:32 AM
Updated 07/09/2023, 06:31 AM

AXT Inc (NASDAQ:AXTI) is doing very well moving up the ranks. Over the course of the last couple weeks this stock has done very well. It’s in a rising channel, and pulled back slightly, but, for me, Thursday was a breakout day, popping 35 cents, or 4.8%, to 7.60, on 836,765 shares traded. There is some resistance where the snapback high and another high came in. That may be a difficult takeout at the 7.85-.95 zone. That’s my immediate target. If it gets through that, I’m looking at 8 1/4-3/4 at the old high. More importantly, look at the long-term chart. It’s a beautiful chart and has been spinning, or consolidating all year so far, coming down, popping up, and coming down again. For me, once it reaches my target, it’s free sailing to 10 and then 12. It has 3.8 days to cover .

Century Aluminum Co. (NASDAQ:CENX) had a very nice recovery. I was really worried about the pullback. Look how it held around the 50, and near the bottom trendline, not far from the major trendline. Coming off that, bouncing and forming a flag, it broke out. On Thursday, it was up another 66 cents, or 3.7%, to 18.34, on 2.7 million shares traded, with 5.8 days to cover short. As the next targets, I’m looking at 20 and 24.

The Direxion Daily S&P Biotech Bull 3X ETF (NYSE:LABU) broke out, pulled back, formed a nice little flag, or wedge, it had a nice volume day, and then stalled right at resistance. For about two weeks it couldn’t get through resistance. On Thursday, it did break out, and jumped 2.64, or 3.9%, to 70.05, on 2.2 million shares traded. We’ll be watching 73.00-73.07 on Friday, and if it gets through that, it’s headed toward 80.00. Biotech’s may be on the verge of a big move.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

MagnaChip Semiconductor Corporation (NYSE:MX) is one of our favorites. After holding near support, it popped on Thursday, advancing 35 cents, or 3%, to 11.35, on 452,103 shares traded. It will probably need to get to 11.60-.65, and run toward 13.00 and 15.00, which are my next targets.

On the long side, stocks included AbbVie Inc. (NYSE:ABBV), ADTRAN, Inc. (NASDAQ:ADTN), AXT Inc. (AXTI), Century Aluminum Co. (NASDAQ:CENX), Datawatch Corporation (NASDAQ:DWCH), Esperion Therapeutics, Inc. (NASDAQ:ESPR), Blackhawk Network Holdings, Inc. (NASDAQ:HAWK), Kite Pharma, Inc. (NASDAQ:KITE), Direxion Daily S&P Biotech Bull 3X ETF (NYSE:LABU), Seres Therapeutics, Inc. (NASDAQ:MCRB), Kopin Corporation (NASDAQ:KOPN), Seres Therapeutics, Inc. (NASDAQ:MCRB), MagnaChip Semiconductor Corporation (NYSE:MX), Nektar Therapeutics (NASDAQ:NKTR), Impinj, Inc. (NASDAQ:PI), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), and Zion Oil & Gas, Inc. (NASDAQ:ZN).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.